Areas of Focus
- Cell Heterogeneity
- Cell Fate Determination
Work Experience
- 2020-07 to Present - Institute of Zoology, Chinese Academy of Sciences - Group Leader of Cell Heterogeneity and Fate Determination Research Group
- 2016-10 to 2020-06 - Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital - Postdoctoral Fellow
- 2011-09 to 2016-06 - University of Pennsylvania - Postdoctoral Fellow
- 2006-09 to 2011-06 - Beijing Normal University - PhD
Academic Background & Achievements
- 2006-09 to 2011-06 PhD: Beijing Normal University
Publications
- Identification of IRAK1BP1 as a candidate prognostic factor in lung adenocarcinoma, Hezhe Lu, 2023
- Wip1 inhibits neutrophil extracellular traps to promote abscess formation in mice by directly dephosphorylating Coronin-1a, Hezhe Lu, 2023
- Distinct genomic features between osteosarcomas firstly metastasing to bone and to lung, Hezhe Lu, 2023
- Asymmetric Cell Division and Tumor Heterogeneity, Hezhe Lu, 2022
- TGF-β Signaling and Resistance to Cancer Therapy, Hezhe Lu, 2021
- PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas, Hezhe Lu, 2017
- Oncogenica BRAF-induced invadopodia formation and melanoma invasion, Hezhe Lu, 2016
- Exo70 isoform switching upon Epithelial-Mesenchymal transition mediates cancer cell invasion, Hezhe Lu, 2013
- Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation, Hezhe Lu, 2012
- MicroRNA-9 up-regulates E-cadherin through inhibition of NF-κB1-snail1 pathway in melanoma, Hezhe Lu, 2012
- An ESRP-regulated splicing programme is abrogated during the epithelial-mesenchymal transition, Hezhe Lu, 2010
- Cyr61 Is Up-Regulated in Prostate Cancer and Associated With the p53 Gene Status, Hezhe Lu, 2009
